Christopher D. Roberts, Chief Scientific Officer at Black Diamond Therapeutics, Inc. (BDTX), sold 4,773 shares at $31.20 ($149K) on 2020-10-05, disclosed to the SEC on 2020-10-07.
Open-market sale of $149k BDTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.20 | 2,273 | $71K | 47.6% |
| 2 | $31.20 | 2,273 | $71K | 47.6% |
| 3 | $31.99 | 227 | $7K | 4.9% |
| Total | $31.24 avg | 4,773 | $149K | 100% |
| Filing → |
| BDTX | SELL | 2021-03-04 | $65K | — | Filing → |
| BDTX | SELL | 2021-02-04 | $63K | — | Filing → |
| BDTX | SELL | 2021-01-06 | $140K | — | Filing → |